Table 1.

Number of Patients in the Analysis of Efficacy With Various Contraindications for Preoperative ABD in Both Groups

ContraindicationsEpoetin Beta (n = 36)Placebo (n = 36)
Aortic valve stenosis 12 
LVEF < 40% 10 10 
Left coronary main stem stenosis > 50% 
Myocardial infarction < 6 months preoperatively 13 
Heart failure stage NYHA III-IV 
History of unstable angina pectoris 
Exercise capacity < 70 W 
Severe cardiac arrhythmias 
History of TIA or syncope 
Heart rate < 55/min 
Pronounced lung disease 
ContraindicationsEpoetin Beta (n = 36)Placebo (n = 36)
Aortic valve stenosis 12 
LVEF < 40% 10 10 
Left coronary main stem stenosis > 50% 
Myocardial infarction < 6 months preoperatively 13 
Heart failure stage NYHA III-IV 
History of unstable angina pectoris 
Exercise capacity < 70 W 
Severe cardiac arrhythmias 
History of TIA or syncope 
Heart rate < 55/min 
Pronounced lung disease 

Fifteen epoetin beta and 21 placebo patients had 1 contraindication. Two contraindications were present in 14 patients in each group, 3 contraindications in 6 epoetin beta patients and 1 placebo patient. Four contraindications were observed in 1 epoetin beta patient.

Abbreviation: TIA, transient ischemic attack.

Close Modal

or Create an Account

Close Modal
Close Modal